2023 was a tricky year with the biopharma field, with many companies downsizing and restructuring their workforces to stay afloat. There are signs of Restoration, as mergers and acquisitions picked up through the pharmaceutical and lifestyle sciences market while in the latter Element of 2023 and possess continued their upswing https://sites.google.com/view/bio-sites/blog